Authors:
Laske, C
Oschmann, P
Tofighi, J
Kuhne, BS
Diehl, H
Bregenzer, T
Kraus, J
Chatzimanolis, N
Bauer, R
Traupe, H
Kaps, M
Citation: C. Laske et al., Prognostic value of soluble tumor necrosis factor receptors 1 and 2 in multiple sclerosis patients treated with interferon beta-1b, EUR NEUROL, 46(4), 2001, pp. 210-214
Authors:
Laske, C
Oschmann, P
Tofighi, J
Kuehne, SB
Diehl, H
Bregenzer, T
Kraus, J
Bauer, R
Chatzimanolis, N
Kern, A
Traupe, H
Kaps, M
Citation: C. Laske et al., Induction of sTNF-R1 and sTNF-R2 by interferon beta-1b in correlation withclinical and MRI activity, ACT NEUR SC, 103(2), 2001, pp. 105-113
Authors:
Kraus, J
Oschmann, P
Engelhardt, B
Stolz, E
Kuehne, BS
Laske, C
Schaefer, C
Traupe, H
Kaps, M
Citation: J. Kraus et al., CD45RA(+) ICAM-3(+) lymphocytes in cerebrospinal fluid and blood as markers of disease activity in patients with multiple sclerosis, ACT NEUR SC, 102(5), 2000, pp. 326-332
Authors:
Laske, C
Gefeller, O
Pfahlberg, A
Zerr, I
Schroter, A
Poser, S
Citation: C. Laske et al., The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: Results of a German pilot case-control study, EUR J EPID, 15(7), 1999, pp. 631-635
Authors:
Kropp, S
Finkenstaedt, M
Laske, C
Schulz-Schaeffer, W
Zerr, I
Kretschmar, A
Poser, S
Citation: S. Kropp et al., Value of diffusion-weighted magnetic resonance image in Creutzfeldt-Jakob disease (vol 245, pg 395, 1998), J NEUROL, 246(1), 1999, pp. 66-66